Pinnacle Associates’s Myriad Genetics MYGN Stock Holding History

Pinnacle Associates’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-10,678	Closed	-$139K	–	712
2020 Q3	$139K	Sell	10,678 -294,505	-97%	-$3.83M	﹤0.01%	655
2020 Q2	$3.46M	Sell	305,183 -11,745	-4%	-$133K	0.09%	215
2020 Q1	$4.54M	Sell	316,928 -64,673	-17%	-$925K	0.14%	165
2019 Q4	$10.4M	Sell	381,601 -30,980	-8%	-$844K	0.23%	122
2019 Q3	$11.8M	Sell	412,581 -28,157	-6%	-$806K	0.28%	100
2019 Q2	$12.2M	Sell	440,738 -39,099	-8%	-$1.09M	0.29%	95
2019 Q1	$15.9M	Buy	479,837 +7,200	+2%	+$239K	0.36%	78
2018 Q4	$13.7M	Sell	472,637 -24,694	-5%	-$718K	0.35%	80
2018 Q3	$22.9M	Sell	497,331 -79,442	-14%	-$3.65M	0.47%	60
2018 Q2	$21.6M	Sell	576,773 -102,270	-15%	-$3.82M	0.44%	63
2018 Q1	$20.1M	Sell	679,043 -32,444	-5%	-$959K	0.39%	73
2017 Q4	$24.4M	Sell	711,487 -67,794	-9%	-$2.33M	0.47%	62
2017 Q3	$28.2M	Sell	779,281 -21,650	-3%	-$783K	0.52%	58
2017 Q2	$20.7M	Sell	800,931 -33,025	-4%	-$853K	0.4%	73
2017 Q1	$16M	Sell	833,956 -37,077	-4%	-$712K	0.31%	92
2016 Q4	$14.5M	Sell	871,033 -51,703	-6%	-$862K	0.29%	97
2016 Q3	$19M	Sell	922,736 -13,440	-1%	-$277K	0.38%	80
2016 Q2	$28.6M	Sell	936,176 -13,443	-1%	-$411K	0.62%	41
2016 Q1	$35.5M	Buy	949,619 +5,110	+0.5%	+$191K	0.76%	33
2015 Q4	$40.8M	Sell	944,509 -58,351	-6%	-$2.52M	0.86%	29
2015 Q3	$37.6M	Sell	1,002,860 -28,800	-3%	-$1.08M	0.83%	30
2015 Q2	$35.1M	Sell	1,031,660 -30,770	-3%	-$1.05M	0.65%	38
2015 Q1	$37.6M	Sell	1,062,430 -4,121	-0.4%	-$146K	0.7%	32
2014 Q4	$36.3M	Buy	1,066,551 +52,405	+5%	+$1.78M	0.71%	33
2014 Q3	$39.1M	Sell	1,014,146 -42,474	-4%	-$1.64M	0.8%	28
2014 Q2	$41.1M	Sell	1,056,620 -66,467	-6%	-$2.59M	0.8%	32
2014 Q1	$38.4M	Sell	1,123,087 -49,840	-4%	-$1.7M	0.75%	36
2013 Q4	$24.6M	Sell	1,172,927 -29,900	-2%	-$627K	0.48%	58
2013 Q3	$28.3M	Sell	1,202,827 -66,029	-5%	-$1.55M	0.58%	41
2013 Q2	$34.1M	Buy	+1,268,856	New	+$34.1M	0.77%	34